The activation of AKT inhibits apoptosis and stimulates tumor progression, inactivating pro-apoptotic proteins such as procaspase 9, BCL2, an associated agonist of cell death (BAD), and apoptosis signal-regulating kinase 1 (ASK1) in ccRCC cells. This evidence concerns the gene MAP3K5 and nonpapillary renal cell carcinoma.